CD133
CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. In this study, we demonstrate that CD133 and a...
Saved in:
Published in | PloS one Vol. 4; no. 5; p. e5498 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Public Library of Science
11.05.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion. The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow-cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells. |
---|---|
AbstractList | Background CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. Methodology/Principal Findings In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion. Conclusions The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow-cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells. CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion. The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow-cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells. |
Audience | Academic |
Author | Pollard, Steve Sun, Yirui Falk, Anna Zhou, Liangfu Kong, Weiqing Smith, Austin Hu, Jin |
Author_xml | – sequence: 1 fullname: Sun, Yirui – sequence: 2 fullname: Kong, Weiqing – sequence: 3 fullname: Falk, Anna – sequence: 4 fullname: Hu, Jin – sequence: 5 fullname: Zhou, Liangfu – sequence: 6 fullname: Pollard, Steve – sequence: 7 fullname: Smith, Austin |
BookMark | eNqFzE9LwzAYBvAgG7hNv4FnwUNrkjdJk-Oo_waDgQ6vJU3edhshEdOCH9-BHurJ0_Pw8ONZkllMEQm5YbRkULH7Uxo_ow3lx3kuKaVSGH1BFswALxSnMJv0S7LM-XQ2oJVakHn9wACuyLyzIeP1b67I_ulxX78U293zpl5vi94YXjjTsk5xR8Fo8ABtJRSVHlFQb7hvHSquvRSoUUkUCqkF20lrKuqF0wZW5O7ntrcBm2N0KQ74NfR2zLnZvL02a1EBU5or_o_dvf-1txN7QBuGQ05hHI4p5in8BnYaVT8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2009 Public Library of Science |
Copyright_xml | – notice: COPYRIGHT 2009 Public Library of Science |
DBID | IOV ISR |
DOI | 10.1371/journal.pone.0005498 |
DatabaseName | Opposing Viewpoints Resource Center Science in Context |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1932-6203 |
ExternalDocumentID | A473168262 |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM |
ID | FETCH-LOGICAL-g992-c9b1f62c03983d33b74605dee40d92dbce628d54e8e65e46e0a3af5a970d4c893 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sat Sep 28 21:18:19 EDT 2024 Sat Sep 28 21:06:05 EDT 2024 Tue Aug 13 02:41:15 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-g992-c9b1f62c03983d33b74605dee40d92dbce628d54e8e65e46e0a3af5a970d4c893 |
PageCount | e5498 |
ParticipantIDs | gale_incontextgauss_ISR_A473168262 gale_incontextgauss_IOV_A473168262 gale_healthsolutions_A473168262 |
PublicationCentury | 2000 |
PublicationDate | 20090511 |
PublicationDateYYYYMMDD | 2009-05-11 |
PublicationDate_xml | – month: 05 year: 2009 text: 20090511 day: 11 |
PublicationDecade | 2000 |
PublicationTitle | PloS one |
PublicationYear | 2009 |
Publisher | Public Library of Science |
Publisher_xml | – name: Public Library of Science |
SSID | ssj0053866 |
Score | 1.9609663 |
Snippet | Background CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue.... CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the... |
SourceID | gale |
SourceType | Aggregation Database |
StartPage | e5498 |
SubjectTerms | B cells Brain tumors Neurophysiology RNA Stem cells |
Title | CD133 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NTwIxEJ0gXLwY8SN-IjEe9FDS7XaX3YMxiBA0AQ2C4Uba7SwXsyoLif5721IIB024zzbdbWfnTWbmPYArRalAjpygQEq45CmJGSJBjIRKjX605e7s9sLOkD-NglEBlpqt7gPmf6Z2Rk9qOH2vfX_93GmHv7WqDXVv-VDt8yPDmgUhcbQFJaZjo2ny6vJVXUF7t61eGtRCQkZ9N0z33yruP70Wcdq7sOOgYrWxONsyFDDbg7Jzxrx67Rijb_ah1HzQSeABDNqtQbNDnL4BmZiezySWXhqyhPpx5Cvfl3VTo1SInKqYKZlgyCIVcIwwDJCHSIUv0kDEdap4onHGIRQzvdkjqApDomOQh2F_E4mKUp0l6HWkUIHkKI7hwrzHeDFbubrU4wa3wlUsZMdwaS0MJURmek4mYp7n48fntw2MXvtrRiebGJ3C9qIsExDPO4PibDrHcx3dZ7ICpftW76VfsdlxxR7fL3udoug |
link.rule.ids | 314,780,784,864,2221,24318,27924,27925 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD133&rft.jtitle=PloS+one&rft.au=Sun%2C+Yirui&rft.au=Kong%2C+Weiqing&rft.au=Falk%2C+Anna&rft.au=Hu%2C+Jin&rft.date=2009-05-11&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=4&rft.issue=5&rft.spage=e5498&rft_id=info:doi/10.1371%2Fjournal.pone.0005498&rft.externalDBID=ISR&rft.externalDocID=A473168262 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |